BDBM650995 (5aRa,18aRa)-2-[(2S,5R)-2,5- dimethyl-4-(prop-2- enoyl)piperazin-1-yl]- 12,12,16,18,21-pentafluoro- 6-(propan-2-yl)-10,11,12,13- tetrahydro-4H-1,19- (ethanediylidene)pyrido[4,3- f]pyrimido[1,6-h][1,8,10] benzoxadiazacyclotri- decin-4-one::US20240043448, Example 56

SMILES CC(C)c1nccc2CCC(F)(F)COc3cc(F)cc(F)c3-c3nc4n(-c12)c(=O)nc(N1CC(C)N(CC1C)C(=O)C=C)c4cc3F

InChI Key InChIKey=CSHJZSBQLXSLJO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 650995   

TargetGTPase KRas [2-169,G12C,C51S,C80L,C118S](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM650995((5aRa,18aRa)-2-[(2S,5R)-2,5- dimethyl-4-(prop-2- e...)
Affinity DataIC50: 1.10nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series in a 384-well low dead volume microplate (Labc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
Go to US Patent